The role of low-dose anti-thymocyte globulin as standard prophylaxis in mismatched and matched unrelated hematopoietic peripheral stem cell transplantation for hematologic malignancies

Anti-thymocyte globulin (ATG) - based immunosuppressive therapy is often used in allogeneic hematopoietic cell transplantation (alloHCT) to reduce incidence and severity of graft-vs-host disease (GVHD).

Source: Clinical Lymphoma, Myeloma and Leukemia - June 28, 2017 Category: Hematology Authors: Ioanna Sakellari, Ioannis Batsis, Zoi Bousiou, Despina Mallouri, Varnavas Constantinou, Eleni Gavriilaki, Christos Smias, Evangelia Yannaki, Panayotis Kaloyannidis, Giorgos Papaioannou, Niki Stavroyianni, Antonia Syrigou, Damianos Sotiropoulos, Asimina Fy Tags: Original Study Source Type: research